HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yang Luo Selected Research

Phosphoribosyl Pyrophosphate

7/2022PRPS2 Enhances Resistance to Cisplatin via Facilitating Exosomes-mediated Macrophage M2 Polarization in Non-small Cell Lung Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yang Luo Research Topics

Disease

100Neoplasms (Cancer)
08/2022 - 04/2002
53Breast Neoplasms (Breast Cancer)
06/2022 - 06/2012
25Neoplasm Metastasis (Metastasis)
06/2022 - 06/2007
19Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 09/2007
17Inflammation (Inflammations)
11/2022 - 07/2010
16Triple Negative Breast Neoplasms
01/2022 - 01/2015
15Infections
01/2022 - 01/2014
10Urinary Bladder Neoplasms (Bladder Cancer)
01/2020 - 11/2013
10Stomach Neoplasms (Stomach Cancer)
12/2018 - 06/2007
8Carcinoma (Carcinomatosis)
01/2022 - 12/2003
7Pain (Aches)
04/2022 - 11/2015
7Carcinogenesis
01/2022 - 02/2011
6Cognitive Dysfunction
01/2022 - 01/2020
6Lung Neoplasms (Lung Cancer)
12/2021 - 09/2016
5Wounds and Injuries (Trauma)
04/2022 - 01/2013
5Stroke (Strokes)
01/2022 - 01/2014
5COVID-19
01/2022 - 01/2020
5Autoimmune Diseases (Autoimmune Disease)
01/2022 - 10/2012
5Intervertebral Disc Degeneration
01/2018 - 08/2013
5Lymphatic Metastasis
01/2017 - 09/2007
4Psoriasis (Pustulosis Palmaris et Plantaris)
11/2022 - 01/2020
4Dermatitis
11/2022 - 01/2019
4Atopic Dermatitis (Atopic Eczema)
01/2022 - 01/2019
4Cicatrix (Scar)
01/2022 - 10/2013
4Thrombocytopenia (Thrombopenia)
01/2022 - 05/2018
4Spinal Cord Injuries (Spinal Cord Injury)
01/2022 - 11/2015
4Neutropenia
01/2022 - 10/2015
4Osteoporosis
01/2022 - 08/2013
4Skin Diseases (Skin Disease)
01/2022 - 06/2014
4Disease Progression
10/2021 - 11/2013
4Hepatocellular Carcinoma (Hepatoma)
01/2021 - 07/2008
4Necrosis
11/2020 - 11/2015
4Colitis
10/2020 - 01/2016
4Ulcerative Colitis
10/2020 - 01/2016
4B-Cell Lymphoma (Lymphoma, B Cell)
01/2020 - 01/2014
3Rheumatoid Arthritis
01/2022 - 10/2018
3Adenocarcinoma of Lung
01/2022 - 02/2009
3Glioma (Gliomas)
08/2021 - 01/2019
3Hypertension (High Blood Pressure)
03/2021 - 11/2016

Drug/Important Bio-Agent (IBA)

42Proteins (Proteins, Gene)FDA Link
06/2022 - 02/2009
21Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2011
13AnthracyclinesIBA
01/2022 - 09/2014
12Pharmaceutical PreparationsIBA
05/2022 - 08/2013
11Hormones (Hormone)IBA
06/2022 - 01/2015
11MicroRNAs (MicroRNA)IBA
06/2021 - 01/2011
10Biological ProductsIBA
12/2021 - 11/2007
10Cyclin G2IBA
08/2021 - 06/2002
10human ERBB2 proteinIBA
02/2021 - 01/2015
9Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 12/2013
8Indicators and Reagents (Reagents)IBA
06/2022 - 11/2007
8RNA (Ribonucleic Acid)IBA
01/2022 - 04/2004
8Trastuzumab (Herceptin)FDA Link
07/2021 - 02/2013
8Taxoids (Taxanes)IBA
03/2021 - 01/2015
7VaccinesIBA
01/2022 - 11/2013
7ErbB Receptors (EGF Receptor)IBA
12/2021 - 10/2016
7Capecitabine (Xeloda)FDA Link
01/2021 - 01/2015
6Cisplatin (Platino)FDA LinkGeneric
07/2022 - 01/2015
6CateninsIBA
01/2022 - 03/2013
6Messenger RNA (mRNA)IBA
01/2022 - 01/2008
6Epirubicin (Ellence)FDA LinkGeneric
08/2020 - 01/2014
5Small Interfering RNA (siRNA)IBA
11/2022 - 06/2007
5CytokinesIBA
11/2022 - 09/2011
5Long Noncoding RNAIBA
01/2022 - 10/2015
5PlatinumIBA
01/2022 - 10/2015
5Vinorelbine (Navelbine)FDA LinkGeneric
07/2021 - 10/2015
5Interleukin-6 (Interleukin 6)IBA
01/2021 - 09/2011
5Caspase 3 (Caspase-3)IBA
01/2021 - 01/2018
5taxaneIBA
01/2018 - 10/2015
5DNA (Deoxyribonucleic Acid)IBA
09/2017 - 12/2003
4Phenobarbital (Luminal)FDA Link
02/2022 - 01/2014
4AntioxidantsIBA
01/2022 - 11/2015
4EnzymesIBA
01/2022 - 07/2016
4Therapeutic UsesIBA
10/2021 - 11/2015
4Progesterone Receptors (Progesterone Receptor)IBA
10/2021 - 09/2014
4Estrogens (Estrogen)FDA Link
01/2021 - 06/2007
4SincalideFDA Link
01/2021 - 12/2014
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 02/2009
4Monoclonal AntibodiesIBA
07/2020 - 10/2016
4Aromatase InhibitorsIBA
01/2020 - 07/2015
4AcidsIBA
07/2018 - 10/2013
4Cadherins (E-Cadherin)IBA
07/2016 - 04/2002
3Tyrosine Kinase InhibitorsIBA
01/2022 - 09/2017
3LigandsIBA
01/2022 - 02/2009
3Antiviral Agents (Antivirals)IBA
01/2022 - 11/2015
3Circular RNAIBA
01/2022 - 01/2021
3CholesterolIBA
01/2022 - 01/2014
3Sorafenib (BAY 43-9006)FDA Link
01/2022 - 01/2014
3Glucose (Dextrose)FDA LinkGeneric
10/2021 - 01/2014
3Estrogen ReceptorsIBA
10/2021 - 09/2014
3LipidsIBA
03/2021 - 10/2012
3calcipotriene (calcipotriol)FDA LinkGeneric
01/2021 - 01/2019
3InterleukinsIBA
01/2021 - 11/2015

Therapy/Procedure

40Therapeutics
02/2022 - 02/2013
33Drug Therapy (Chemotherapy)
02/2022 - 06/2012
8Neoadjuvant Therapy
01/2022 - 01/2014
8Adjuvant Chemotherapy
01/2022 - 03/2013
6Renal Dialysis (Hemodialysis)
01/2022 - 01/2020
4Immunotherapy
11/2021 - 01/2021
4Length of Stay
09/2019 - 10/2016
3Transplantation
11/2021 - 01/2019